XRONIK KUNDALIK BOSH OG‘RIQLAR VA KOGNITIV PASAYISHNING NEYROPSIXOLOGIK JIHATLARI: KOHORT TADQIQOT MA’LUMOTLARI
;
Shaxsiylashtirilgan davolash, xronik kundalik bosh og‘riqlar, genetik markerlar, qon tomir markerlari, individual davolash, patogenez, hayot sifati.Abstrak
Maqolada xronik kundalik bosh og‘riqlarni shaxsiylashtirilgan davolash masalalari, xususan, genetik va qon tomir markerlarining o‘rni ko‘rib chiqiladi. Irsi omillar va qon tomir tizimining xususiyatlari kasallik patogenezi va davolash samaradorligiga qanday ta’sir ko‘rsatishi tahlil qilinadi. Ushbu markerlarni hisobga olish individual davolash sxemalarini ishlab chiqishga imkon berishi, bu esa davolash samaradorligini oshirish va nojo‘ya ta’sirlarni kamaytirishga yordam berishi ta’kidlanadi. Shaxsiylashtirilgan yondashuvni qo‘llash istiqbollari bemorlarning hayot sifatini yaxshilash uchun alohida ahamiyatga ega ekani qayd etilgan.
Iqtiboslar
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (ICHD-3). Cephalalgia. 2018;38(1):1-211.
Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, Lipton RB. Chronic migraine prevalence, disability, and sociodemographic factors. Headache. 2012;52(10):1456-1470.
Chong CD, Schwedt TJ. Migraine affects white matter tract integrity: a diffusion-tensor imaging study. Cephalalgia. 2015;35(13):1162-1171.
Verhagen AP, Damen L, Berger MY, et al. Prognosis of chronic daily headache in primary care. J Headache Pain. 2010;11(3):151-158.
Grazzi L, Raggi A. Cognitive and psychological features in patients with chronic migraine. Neurol Sci. 2020;41(Suppl 2):477-480.
Olesen J, et al. The burden of migraine and tension-type headache. Curr Opin Neurol. 2022;35(3):281-287.
